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Abstract 
Background: Multiple risk factors are supposed to progress oral cavity carcinoma and among them, the role of 
neither bacterial nor viral infections should be underestimated. Despite relentless efforts, the accelerating effects 
of human papillomavirus (HPV), Epstein–Barr virus (EBV), and Porphyromonas gingivalis (P. gingivalis) on 
oral cancer has not yet been recognized successfully. Taking advantage of these facts, in this study we evaluated 
the prevalence of HPV, EBV, and P. gingivalis in oral cavity carcinoma. 
Materials and Methods: A total of 43 oral cavity cancerous tissues and 29 healthy oral ones were collected from 
Loghman Hospital, Tehran, Iran, between 2016 and 2018. After DNA extraction, the prevalence of HPV, EBV, 
and P. gingivalis was evaluated by PCR. 
Results: There were 53.5 well-differentiated (15 male, 9 female), 41.8% moderate (10 male, 5 female), and 
4.7% poor (1 male, 3 female) adenocarcinoma paraffin-embedded tissue samples. PCR analysis has shown 
that there were 1 HPV (age: 46; moderate adenocarcinoma) and 1 EBV (age: 62; moderate adenocarcinoma) 
positive in different samples. No P. gingivalis was found and there was not any infected tissue with both EBV 
and HPV. In 31% of control tissues, blisters were observed and in 51.7% there was no mucus. We did not find 
any association between age, sex, and HPV, EBV positive samples. 
Conclusion: As sample size can affect the results of epidemiological and clinical study, and due to the low 
number of positive samples in this study, we concluded that HPV, EBV, and P. gingivalis may not have a 
detrimental effect on the progression of oral cancer, but further studies are needed. 
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Introduction Nowadays, cancers are considered as one of the serious 
health problems worldwide which have a detrimental 
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effect on health care systems. Among many different 
kinds of cancers, it is estimated that the global 
incidence of oral cavity carcinoma has more than 60% 
up-regulation1. Moreover, 1400 new cases per 
100,000 individuals suffer from oral carcinoma in Iran 
annually2. Oral carcinoma is a life-threatening 
disease, with ranging stages from benign to invasive 
malignant tumor which can intervene in the patients' 
lives. Actually, different symptoms, such as pre-
malignant dysplastic lesions with leukoplakia, 
erythroplakia, or a combination of two can be 
associated with oral cavity carcinoma3. Although 
there are a lot of progressions in detecting this disease 
in the early stages, oral cavity carcinoma accounts for 
a high rate of mortality. As chemo-resistance in oral 
cancer is observed and the carcinoma cells are able to 
spread in all parts of the body, this health problem can 
be classified as an incurable disease4,5. Previous 
studies suggest that some risk factors can play a 
crucial role in this disease. The consumption of tobaco 
and alcohol, low intake of fruit and vegetable and poor 
oral hygiene, family history of this cancer, body mass 
index (BMI), personal medical history, and even tea 
consumption has an effect on the progression of oral 
carcinoma6-10. Moreover, the role of neither viral nor 
bacterial risk factors should be underestimated. These 
factors can express different oncoproteins and lead to 
cell division11.  
Human papillomavirus (HPV) is one of the viral risk 
factors which has a double-stranded DNA genome12. 
This virus with some oncoproteins, such as E6 and E7 
can stimulate the division of cells and deteriorate the 
situation of patients, suffering from different kinds of 
cancers. Some cancers have a direct relationship with 
this virus, for example, the relationship between 
cervical cancer and HPV has been confirmed. E6 is 
able to destroy the structure of P53 with ubiquitin, and 
E7 can separate the Rb from E2F; hence, the protein 
overexpression may be observed in cells13-15. 
Furthermore, herpesviridea, especially Epstein–Barr 
virus (EBV), is supposed as one of the infectious risk 
factors to progress cancer16. This family possesses 
some special strategies to escape from the immune 
system. Recurrence and latency are observed in some 
of the virus members of this family; therefore, in most 
of patients who suffer from immune deficiency, 
herpesviridea, especially EBV, may cause serious 
health problems17. In previous studies, the association 
between EBV and gastric cancer by using some 
oncoprotein, such as LMP1 and EBNA-1 was 
reported18,19. 
Apart from HPV and EBV, there is an argument that 
Porphyromonas gingivalis (P. gingivalis) can stimulate 
cell division. This bacterium belongs to gram-negative 
bacteria, and is able to express serine-glycine dipeptide 
lipid classes which can engage human Toll-like 
receptor 2 (TLR2), and induce tumor necrosis factor 
alpha (TNF-α) expression; therefore, inflammation and 
cancer may be observed20. 
As the prevalence of EBV, HPV, and P. gingivalis in 
oral cavity carcinoma is not yet clear, in this study we 
evaluated the HPV, EBV, and P. gingivalis prevalence 
in this type of cancer. 
Methods 
Samples  
This study has been submitted and approved by the 
ethics committee of Shahid Beheshti University of 
Medical Sciences, School of Medicine (SBMU. 
IR.SBMU.RETECH.REC.1397.456). In this case-
control study, 43 oral cavity cancer and 29 healthy oral 
tissues were collected from Loghman Hospital, Tehran, 
Iran, between 2016 and 2018.  
DNA extraction 
After removing paraffin  digesting tissues by 1ml 
xylene for 3 hours, and digesting buffer containing 
proteinase K, the DNA of all samples was extracted by 
Exgene (GeneAll, Seoul, Korea), and eluded in 50 μl of 
elution, according to manufacturer’s protocol21. 
β-globin gene PCR 
As an internal control, the β-globin gene was employed 
to evaluate and confirm the quality of samples DNA. In 
this study, we used 12.5 µl master mix, 1 µl forward 
and 1 µl reverse primer (10 pmol), 1 µl DNA and 8.5 µl 
sterile water in final 25 μl in following PCR procedure: 
5 min in 95°C as the first denaturation, 30 cycles of 
95°C for 30s, 55°C for 30s, 72°C for 30s and 72°C for 
7 min. Every negative β-globin gene was double-
checked.  
PCR 
We investigated HPV, EBV, and P. gingivalis 
prevalence in three different PCR schedules. In final 25 
µl, we combined 12 µl PCR master mix 5X (Cinaclone, 
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Iran), including 8 µl sterile distilled water, 2 µl DNA 
template, 1.5 µl forward and 1.5 µl reverses primers, 
and incubated in following PCR temperature. PCR 
temperature for HPV: 5 min in 94°C as first 
denaturation, 29 cycles of 94°C for 30s, 48°C for 30s, 
72°C for 30s and 72°C for 7 min. PCR schedule for 
EBV: 5 min in 94°C as first denaturation, 29 cycles of 
94°C for 30s, 56°C for 30s, 72°C for 45s and 72°C for 
10 min. And PCR for P. gingivalis: 5 min in 94°C as 
first denaturation, 29 cycles of 94°C for 30s, 54°C for 
30s, 72°C for 30s and 72°C for 10 min. (The primers 
were presented in Table.1). The PCR products were 
run in 2% in gel electrophoresis21. 
Statistical analysis 
All data were assessed by IBM SPSS Statistics 
software version 22, and Chi-square test to find the 
relationship between patient’s sex, age, and the 
prevalence of EBV, HPV, and P. gingivalis. P-value 
less than 0.05 were considered meaningful.  
This study was financially supported by the Infectious 
diseases and tropical medicine research center, Shahid 
Beheshti University of Medical Sciences, Tehran, 
Iran. 
Results 
To evaluate the prevalence of HPV, EBV, and P. 
gingivalis, 43 cancerous embedded paraffin tissues 
[26 males (60.5%) and 17 females (39.5%)] were 
collected. The mean age was 59.72 (max: 97 and min: 
19). 29 matched control samples were also included. 
There were 53.5% well-differentiated (15 males, 9 
female), 41.8% moderate (10 males, 5 female), and 
4.7% poor (1 male, 3 female) adenocarcinoma. PCR 
analysis has shown that there were 1 HPV (age: 46; 
moderate adenocarcinoma) and 1 EBV (age: 62; 
moderate adenocarcinoma) positive in different 
samples. No P. gingivalis was found and there was not 
any infected tissue with both EBV and HPV. In 31% of 
control tissues, blisters were observed and in 51.7% 
there was no mucus. All control tissues were negative. 
Positive samples were EBNA-1, HeLa cell line, and 
positive sample collected from hospital for EBV, HPV 
and P. gingivalis, respectively. We did not find any 
association between age, sex, and HPV, EBV positive 
samples. 
Discussion 
Oral cavity carcinoma can be supposed as one of the 
major reasons of mortality. Studies reported that about 
60% of patients suffering from oral cavity carcinoma, 
have stage III or IV of this cancer21. Alcohol, smoking, 
age, sex, and high fat diet have a detrimental effect on 
this kind of cancer. For example, there is a higher 
chance (about 10 to 15 times) in the smoker to get oral 
cavity carcinoma23,24. Many studies made an effort to 
identify the novel biomarkers which can induce cells to 
divide uncontrollably. Investigations showed that 
infectious risk factors can be considered as one of the 
main causes of oral cavity carcinoma. As some different 
infections are able to express oncogenes, these risk 
factors can progress cancer diseases, especially oral 
cavity carcinoma. Recent studies have shown that HPV 
oncogenes (E6 and E7) are able to knock down P53 and 
deregulate the protein expression25. 
There were 1 HPV (age: 46; moderate adenocarcinoma) 
and 1 EBV (age: 62; moderate adenocarcinoma) 
positive in different samples. No P. gingivalis was 
found and there was not any infected tissue with both 
EBV and HPV. Other studies showed different rates of 
HPV prevalence in different parts of the world. For 
example, it was reported that there was not any 
relationship between HPV and oral squamous cell 
carcinoma (SCC) of the oral tongue, in non-smoking 
and non-drinking patients between 2003 and 200626. 
Table 1: The primers sequence for PCR procedure. 
GAPDH forward GGTGCTAAGCAGTTGGTGGT 
GAPDH reverse GGTACACCTGCAGACACCATTGAT 
HPV forward CGGACAGAGCCCATTACAATATT 
HPV reverse CGCACAACCGAAGCGTAGA 
EBV forward GATTCAGGCGTGGTCCTTGG 
EBV reverse CCGAAGAGGTTGAAAACAAA 
P. gingivalis forward GCGTATGCA ACTTGCCTTAC 
P. gingivalis reverse GTTTCAACGGCAGGCTGAAC 
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In another study executed by Shih-Wei Yang, HPV 
was not introduced as a prognostic indicator of 
malignant transformation in oral leukoplakia27. In 
2020, among 50 patients, there were no HPV positive 
tissues and it was reported that p16INK4a expression 
was not dependent on the presence of HPV in patients 
suffering from oral cancer28. However, some other 
studies detected HPV in oral cancer tissues. For 
example, Janecka-Widła showed that more than 20% 
of patients were infected with HPV. [81.25% HPV-16, 
9.38% HPV-35, and double infections with HPV-16 
and 35 (6.25%) or HPV-35 and 18 (3.12%)]29. In 
2020, 94 out of 158 were HPV positive, resulted that 
HPV has a strong impact on oral cavity carcinoma30. 
 In Qatar, one of the Iran's neighbor countries, HPV 
types 59 (54.8%), 31 (53.7%), 52 (49.1%), 51 
(48.6%), 58 (47%), and 35 (45.5%) had higher 
prevalence31. Among 96 patients (23 female/73 male), 
HPV was detected in 112 patients (19 female/93 male) 
in 202032. About 61% of patients, HPV-16 was 
positive33. 
Another virus evaluated in this study was EBV. Our 
results indicated one positive EBV tissue; therefore, 
EBV may not involve in progressing the oral cancer. 
Some studies reported similar results, for example, in 
the study of Torben Wilms, there was no evidence of 
EBV presence in squamous cell carcinoma of the 
mobile tongue34. In India, there was a higher 
prevalence of EBV in control samples than cancerous 
tissues35. In some other investigations in 2018, the role 
of EBV and HPV DNA in accelerating the oral cavity 
cancer progression was emphasized 36. In Thailand, a 
tight relationship between EBV and oral cancer was 
reported37 and 27.3% of all samples were EBV 
positive, and 7.8% of samples were infected with both 
HPV and EBV38. 
In this study, we did not detect any P. gingivalis. It 
was reported that P. gingivalis has a profound impact 
on oral cancer by upregulating IL-8 and MMPs39. By 
blocking apoptotic pathways in gingival epithelial 
cells, P. gingivalis can prevent cells to become 
cancerous40. However, in some other studies, P. 
gingivalis was reported with a higher level (more than 
33%, P<0.05) in cancerous tissues41. By changing in 
epithelial-mesenchymal transition-like, P. gingivalis 
can increase the chance of oral cancer diseases42. This 
bacterium may be able to interact with TLRs and 
stimulate the division of oral cells43. 
Conclusion 
As sample size can affect the results of epidemiological 
and clinical study, and due to the low number of 
positive samples in this study, we concluded that HPV, 
EBV, and P. gingivalis may not have a detrimental 
effect on the progression of oral cancer, but further 
studies are needed. 
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